Ou, Huang-Tz

Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review

Yang, C.-Y., Chen, Y.-R., Ou, H.-T., & Kuo, S. (2021) · Cardiovascular Diabetology

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 51

Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future

Kuo, S., Ou, H.-T., & Wang, C. J. (2021) · Journal of the American Pharmacists Association

Pharmaceutical Economics and PolicySupply Chain Resilience and Risk Management

Cited by 47

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis

Chang, K.-C., Shao, S.-C., Kuo, S., Yang, C.-Y., Chen, H.-Y., Chan, Y.-Y., & Ou, H.-T. (2020) · Cardiovascular Diabetology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 28

Cost‐effectiveness of long‐acting insulin analogues vs intermediate/long‐acting human insulin for type 1 diabetes: A population‐based cohort followed over 10 years

Lee, T., Kuo, S., Yang, C., & Ou, H. (2020) · British Journal of Clinical Pharmacology

Diabetes Management and ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 18

Temporal and subgroup disparities in mediation effects on cardiovascular outcomes with liraglutide and semaglutide: a post-hoc analysis of LEADER and SUSTAIN-6 trials

Peng, Z.-Y., Lee, Y.-H., Ou, H.-T., & Kuo, S. (2025) · Cardiovascular Diabetology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 5